Influence of phosphocitrate, a potent inhibitor of hydroxyapatite crystal growth, on mineralization of cartilage and bone

A Hari Reddi, J. L. Meyer, W. P. Tew, J. E. Howard, A. L. Lehninger

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

An in vivo bone induction system was used to study the effect of phosphocitrate, a potent inhibitor of calcium phosphate crystallization, on the initial stages of mineralization. Subcutaneous transplantation of coarse powders of demineralized rat diaphyseal bone matrix into allogenic recipients results in a well defined sequence of mineralization steps involving cartilage formation, calcification and bone formation. Phosphocitrate when administered locally or systemically had no effect on the mineralization of either cartilage or bone. Dose levels were chosen to be consistent with that of a previous study which demonstrated that ethane-1-hydroxy-1, 1-diphosphonate(EHDP), a similarly effective in vitro inhibitor of hydroxyapatite crystallization, has a strong inhibitory effect on the initial mineralization steps. Since EHDP is not metabolized in vivo, the lack of effect of phosphocitrate in this study is suggestive of possible enzymatic hydrolysis at the calcification site which may regulate the level of phosphocitrate.

Original languageEnglish (US)
Pages (from-to)154-159
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume97
Issue number1
DOIs
StatePublished - 1980
Externally publishedYes

Fingerprint

Physiologic Calcification
Cartilage
Durapatite
Crystallization
Bone
Ethane
Diphosphonates
Bone and Bones
Bone Matrix
Enzymatic hydrolysis
Osteogenesis
Powders
Rats
Hydrolysis
Transplantation
phosphocitrate

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Influence of phosphocitrate, a potent inhibitor of hydroxyapatite crystal growth, on mineralization of cartilage and bone. / Reddi, A Hari; Meyer, J. L.; Tew, W. P.; Howard, J. E.; Lehninger, A. L.

In: Biochemical and Biophysical Research Communications, Vol. 97, No. 1, 1980, p. 154-159.

Research output: Contribution to journalArticle

@article{55115e212b4a423b81ee153a33d7f4bb,
title = "Influence of phosphocitrate, a potent inhibitor of hydroxyapatite crystal growth, on mineralization of cartilage and bone",
abstract = "An in vivo bone induction system was used to study the effect of phosphocitrate, a potent inhibitor of calcium phosphate crystallization, on the initial stages of mineralization. Subcutaneous transplantation of coarse powders of demineralized rat diaphyseal bone matrix into allogenic recipients results in a well defined sequence of mineralization steps involving cartilage formation, calcification and bone formation. Phosphocitrate when administered locally or systemically had no effect on the mineralization of either cartilage or bone. Dose levels were chosen to be consistent with that of a previous study which demonstrated that ethane-1-hydroxy-1, 1-diphosphonate(EHDP), a similarly effective in vitro inhibitor of hydroxyapatite crystallization, has a strong inhibitory effect on the initial mineralization steps. Since EHDP is not metabolized in vivo, the lack of effect of phosphocitrate in this study is suggestive of possible enzymatic hydrolysis at the calcification site which may regulate the level of phosphocitrate.",
author = "Reddi, {A Hari} and Meyer, {J. L.} and Tew, {W. P.} and Howard, {J. E.} and Lehninger, {A. L.}",
year = "1980",
doi = "10.1016/S0006-291X(80)80148-3",
language = "English (US)",
volume = "97",
pages = "154--159",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Influence of phosphocitrate, a potent inhibitor of hydroxyapatite crystal growth, on mineralization of cartilage and bone

AU - Reddi, A Hari

AU - Meyer, J. L.

AU - Tew, W. P.

AU - Howard, J. E.

AU - Lehninger, A. L.

PY - 1980

Y1 - 1980

N2 - An in vivo bone induction system was used to study the effect of phosphocitrate, a potent inhibitor of calcium phosphate crystallization, on the initial stages of mineralization. Subcutaneous transplantation of coarse powders of demineralized rat diaphyseal bone matrix into allogenic recipients results in a well defined sequence of mineralization steps involving cartilage formation, calcification and bone formation. Phosphocitrate when administered locally or systemically had no effect on the mineralization of either cartilage or bone. Dose levels were chosen to be consistent with that of a previous study which demonstrated that ethane-1-hydroxy-1, 1-diphosphonate(EHDP), a similarly effective in vitro inhibitor of hydroxyapatite crystallization, has a strong inhibitory effect on the initial mineralization steps. Since EHDP is not metabolized in vivo, the lack of effect of phosphocitrate in this study is suggestive of possible enzymatic hydrolysis at the calcification site which may regulate the level of phosphocitrate.

AB - An in vivo bone induction system was used to study the effect of phosphocitrate, a potent inhibitor of calcium phosphate crystallization, on the initial stages of mineralization. Subcutaneous transplantation of coarse powders of demineralized rat diaphyseal bone matrix into allogenic recipients results in a well defined sequence of mineralization steps involving cartilage formation, calcification and bone formation. Phosphocitrate when administered locally or systemically had no effect on the mineralization of either cartilage or bone. Dose levels were chosen to be consistent with that of a previous study which demonstrated that ethane-1-hydroxy-1, 1-diphosphonate(EHDP), a similarly effective in vitro inhibitor of hydroxyapatite crystallization, has a strong inhibitory effect on the initial mineralization steps. Since EHDP is not metabolized in vivo, the lack of effect of phosphocitrate in this study is suggestive of possible enzymatic hydrolysis at the calcification site which may regulate the level of phosphocitrate.

UR - http://www.scopus.com/inward/record.url?scp=0019277253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019277253&partnerID=8YFLogxK

U2 - 10.1016/S0006-291X(80)80148-3

DO - 10.1016/S0006-291X(80)80148-3

M3 - Article

C2 - 7006600

AN - SCOPUS:0019277253

VL - 97

SP - 154

EP - 159

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -